                               SEQUENCE LISTING

<110> SANGAMO BIOSCIENCES, INC.
 
<120> METHODS AND COMPOSITIONS FOR PREVENTION OR TREATMENT OF A DISEASE

<130> 8325-0119.40

<140> PCT/US2015/030536
<141> 2015-05-13

<150> 61/992,676
<151> 2014-05-13

<160> 28    

<170> PatentIn version 3.5

<210> 1
<211> 110
<212> RNA
<213> Homo sapiens

<400> 1
ggccagcugu gaguguuucu uuggcagugu cuuagcuggu uguugugagc aauaguaagg       60

aagcaaucag caaguauacu gcccuagaag ugcugcacgu uguggggccc                 110


<210> 2
<211> 77
<212> RNA
<213> Homo sapiens

<400> 2
agucuaguua cuaggcagug uaguuagcug auugcuaaua guaccaauca cuaaccacac       60

ggccagguaa aaagauu                                                      77


<210> 3
<211> 28
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
tactgcccta gaagtgctgc acgttgtg                                          28


<210> 4
<211> 28
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
acttgctgat tgcttcctta ctattgct                                          28


<210> 5
<211> 28
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
gtgattggta ctattagcaa tcagctaa                                          28


<210> 6
<211> 28
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
accacacggc caggtaaaaa gatttggg                                          28


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Gln Ser Ser Asp Leu Ser Arg 
1               5           


<210> 8
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Trp Lys Trp Asn Leu Arg Ala 
1               5           


<210> 9
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Gln Asn Ala His Arg Lys Thr 
1               5           


<210> 10
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Asp Arg Ser Asp Leu Ser Arg 
1               5           


<210> 11
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Arg Arg Ser Thr Leu Arg Ser 
1               5           


<210> 12
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Asp Ser Ser Asp Arg Lys Lys 
1               5           


<210> 13
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Tyr Lys Trp Thr Leu Arg Asn 
1               5           


<210> 14
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Arg Ser Asp Val Leu Ser Glu 
1               5           


<210> 15
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Arg Asn Phe Ser Leu Thr Met 
1               5           


<210> 16
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Arg Ser Asp Asn Leu Ser Thr 
1               5           


<210> 17
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Trp Arg Asp Ser Leu Leu Ala 
1               5           


<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Asp Arg Ser Asn Arg Ile Lys 
1               5           


<210> 19
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Arg Ser Asp His Leu Ser Thr 
1               5           


<210> 20
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Thr Ser Ala Asn Leu Ser Arg 
1               5           


<210> 21
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Gln Ser Ala Asn Arg Thr Lys 
1               5           


<210> 22
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Arg Ser Ala His Leu Ser Arg 
1               5           


<210> 23
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Arg Ser Asp Thr Leu Ser Thr 
1               5           


<210> 24
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Asp Ser Ser Asn Arg Ile Asn 
1               5           


<210> 25
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 25
gttgccagcc atctgttgtt t                                                 21


<210> 26
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 26
gacagtggga gtggcacctt                                                   20


<210> 27
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 27
ctcccccgtg ccttccttga cc                                                22


<210> 28
<211> 9
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 'LAGLIDADG' family motif
      peptide

<400> 28
Leu Ala Gly Leu Ile Asp Ala Asp Gly 
1               5                   


